Cargando…
A Double-Blind, Randomized, Active Drug Comparative, Parallel-Group, Multi-Center Clinical Study to Evaluate the Safety and Efficacy of Probiotics (Bacillus licheniformis, Zhengchangsheng® capsule) in Patients with Diarrhea
BACKGROUND/AIMS: Bacillus Licheniformis, a probiotic used in the treatment of diarrhea, has been shown to suppress the growth of pathologic bacteria. This study was performed to assess the therapeutic efficacy and safety of Zhengchangsheng® (Bacillus Licheniformis) in comparison with another probiot...
Autores principales: | Heo, Jun, Kim, Sung Kook, Park, Kyung Sik, Jung, Hye Kyung, Kwon, Joong Goo, Jang, Byung Ik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204727/ https://www.ncbi.nlm.nih.gov/pubmed/25349598 http://dx.doi.org/10.5217/ir.2014.12.3.236 |
Ejemplares similares
-
Oral Supplements of Combined Bacillus licheniformis Zhengchangsheng® and Xylooligosaccharides Improve High-Fat Diet-Induced Obesity and Modulate the Gut Microbiota in Rats
por: Li, Yuyuan, et al.
Publicado: (2020) -
Bacillus licheniformis and Bacillus subtilis, Probiotics That Induce the Formation of Macrophage Extracellular Traps
por: Romo-Barrera, Carol M., et al.
Publicado: (2021) -
Probiotic characteristics and zearalenone-removal ability of a Bacillus licheniformis strain
por: Hsu, Tsui-Chun, et al.
Publicado: (2018) -
Baseline gut microbiome impacts probiotics Bacillus licheniformis CMCC63516 in modulating the gut microbiome and preventing antibiotic‐associated diarrhea: A double‐blind, randomized controlled trial
por: Zhou, Qian, et al.
Publicado: (2023) -
Cryoprotection of probiotic bacteria with poly-γ-glutamic acid produced by Bacillus subtilis and Bacillus licheniformis
por: Gomaa, Eman Zakaria
Publicado: (2016)